Nephros Inc (NEPH) stock
NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3020% below fair value
$3.31+0.24 (+7.82%)
Close on Nov 12, 2026Market cap $35.95MP/E 18.4Yield –
Nephros total assets
Total assets on the balance sheet at the end of each period.
Nephros's total assets was $15.31M at Sep 30, 2026. For fiscal 2025 it was $13.64M, up 21.7% from the year before. Over ten years it grew 13.1% a year on average. The highest annual figure on record is $18.51M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.64M | +21.7% |
| FY2024 | Dec 31, 2024 | $11.21M | -5.5% |
| FY2023 | Dec 31, 2023 | $11.86M | +7.8% |
| FY2022 | Dec 31, 2022 | $11.00M | -37.7% |
| FY2021 | Dec 31, 2021 | $17.65M | -4.6% |
| FY2020 | Dec 31, 2020 | $18.51M | +59.2% |
| FY2019 | Dec 31, 2019 | $11.63M | +10.1% |
| FY2018 | Dec 31, 2018 | $10.56M | +111.9% |
| FY2017 | Dec 31, 2017 | $4.98M | +86.1% |
| FY2016 | Dec 31, 2016 | $2.68M | -32.5% |
| FY2015 | Dec 31, 2015 | $3.97M | +17.8% |
| FY2014 | Dec 31, 2014 | $3.37M | +16.6% |
| FY2013 | Dec 31, 2013 | $2.89M | -18.1% |
| FY2012 | Dec 31, 2012 | $3.53M | -11.7% |
| FY2011 | Dec 31, 2011 | $3.99M | +151.2% |
| FY2010 | Dec 31, 2010 | $1.59M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $15.31M | +15.5% |
| Q2 FY2026 | Jun 30, 2026 | $15.77M | +28.8% |
| Q1 FY2026 | Mar 31, 2026 | $13.79M | +17.1% |
| Q4 FY2025 | Dec 31, 2025 | $13.64M | +21.7% |
| Q3 FY2025 | Sep 30, 2025 | $13.25M | +27.5% |
| Q2 FY2025 | Jun 30, 2025 | $12.24M | +10.3% |
| Q1 FY2025 | Mar 31, 2025 | $11.78M | +3.2% |
| Q4 FY2024 | Dec 31, 2024 | $11.21M | -5.5% |
| Q3 FY2024 | Sep 30, 2024 | $10.39M | -4.9% |
| Q2 FY2024 | Jun 30, 2024 | $11.10M | +6.9% |
| Q1 FY2024 | Mar 31, 2024 | $11.42M | +4.5% |
| Q4 FY2023 | Dec 31, 2023 | $11.86M | +7.8% |
| Q3 FY2023 | Sep 30, 2023 | $10.92M | -3.7% |
| Q2 FY2023 | Jun 30, 2023 | $10.39M | -30.5% |
| Q1 FY2023 | Mar 31, 2023 | $10.93M | -29.6% |
| Q4 FY2022 | Dec 31, 2022 | $11.00M | -37.7% |
| Q3 FY2022 | Sep 30, 2022 | $11.34M | -36.4% |
| Q2 FY2022 | Jun 30, 2022 | $14.95M | -16.9% |
| Q1 FY2022 | Mar 31, 2022 | $15.53M | -13.4% |
| Q4 FY2021 | Dec 31, 2021 | $17.65M | -4.6% |
| Q3 FY2021 | Sep 30, 2021 | $17.82M | +16.9% |
| Q2 FY2021 | Jun 30, 2021 | $17.99M | +8.1% |
| Q1 FY2021 | Mar 31, 2021 | $17.94M | -2.0% |
| Q4 FY2020 | Dec 31, 2020 | $18.51M | +59.2% |
| Q3 FY2020 | Sep 30, 2020 | $15.24M | +31.9% |
| Q2 FY2020 | Jun 30, 2020 | $16.65M | +38.6% |
| Q1 FY2020 | Mar 31, 2020 | $18.29M | +80.4% |
| Q4 FY2019 | Dec 31, 2019 | $11.63M | +10.1% |
| Q3 FY2019 | Sep 30, 2019 | $11.55M | +22.9% |
| Q2 FY2019 | Jun 30, 2019 | $12.01M | +75.5% |
| Q1 FY2019 | Mar 31, 2019 | $10.14M | +118.9% |
| Q4 FY2018 | Dec 31, 2018 | $10.56M | +111.9% |
| Q3 FY2018 | Sep 30, 2018 | $9.40M | +233.0% |
| Q2 FY2018 | Jun 30, 2018 | $6.85M | +140.9% |
| Q1 FY2018 | Mar 31, 2018 | $4.63M | +41.3% |
| Q4 FY2017 | Dec 31, 2017 | $4.98M | +86.1% |
| Q3 FY2017 | Sep 30, 2017 | $2.82M | – |
| Q2 FY2017 | Jun 30, 2017 | $2.84M | – |
| Q1 FY2017 | Mar 31, 2017 | $3.28M | – |
| Q4 FY2016 | Dec 31, 2016 | $2.68M | – |
See a number that looks wrong?